No advantage of the combination of ACE-inhibition and angiotensin receptor blockade in patients with high cardiovascular risk

Ton van den Meiracker

Research output: Contribution to journalArticleAcademic

1 Citation (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1358-1360
Number of pages3
JournalNederlands Tijdschrift voor Geneeskunde
Volume152
Publication statusPublished - 2008

Research programs

  • EMC COEUR-01-43-01

Cite this